A new framework for erythropoiesis-stimulating agent resistance based on body mass index-fat tissue index classification.
作者信息
Ito Hiroki, Mori Takefumi
机构信息
Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
出版信息
Kidney Res Clin Pract. 2025 Jun 10;44(5):850-2. doi: 10.23876/j.krcp.25.073.
Abstract
摘要
相似文献
1
A new framework for erythropoiesis-stimulating agent resistance based on body mass index-fat tissue index classification.一种基于体重指数-脂肪组织指数分类的促红细胞生成素抵抗新框架。
Kidney Res Clin Pract. 2025 Jun 10;44(5):850-2. doi: 10.23876/j.krcp.25.073.
2
Harms of off-label erythropoiesis-stimulating agents for critically ill people.危重症患者使用非标签促红细胞生成素刺激剂的危害。
Cochrane Database Syst Rev. 2017 Aug 25;8(8):CD010969. doi: 10.1002/14651858.CD010969.pub2.
3
Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.用于类风湿关节炎贫血的促红细胞生成素
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD000332. doi: 10.1002/14651858.CD000332.pub3.
4
Effect of erythropoiesis-stimulating agent types on malignancy in hemodialysis patients.促红细胞生成素类型对血液透析患者恶性肿瘤的影响。
Clin Kidney J. 2025 Jun 16;18(6):sfaf148. doi: 10.1093/ckj/sfaf148. eCollection 2025 Jun.
5
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.促红细胞生成素刺激剂治疗慢性肾脏病成人贫血的网状 Meta 分析。
Cochrane Database Syst Rev. 2023 Feb 13;2(2):CD010590. doi: 10.1002/14651858.CD010590.pub3.
6
Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data.促红细胞生成素对癌症患者疲劳和贫血相关症状的影响：已发表和未发表数据的系统评价与荟萃分析
Br J Cancer. 2014 Jul 8;111(1):33-45. doi: 10.1038/bjc.2014.171. Epub 2014 Apr 17.
8
Attribute based cross classification analyses from the BRIGHTEN study reveal that therapeutic responsiveness to erythropoiesis stimulating agents predicts cardiorenal prognosis in renal anemia.BRIGHTEN研究基于属性的交叉分类分析表明，促红细胞生成素刺激剂的治疗反应性可预测肾性贫血的心肺肾预后。
Sci Rep. 2025 Jul 2;15(1):23221. doi: 10.1038/s41598-025-05762-y.
9
Randomized controlled open-label trial of vitamin E-bonded polysulfone dialyzer and erythropoiesis-stimulating agent response.随机对照开放性试验研究维生素 E 键合聚砜透析器和促红细胞生成刺激剂反应。
Clin J Am Soc Nephrol. 2013 Jun;8(6):969-78. doi: 10.2215/CJN.04680512. Epub 2013 Apr 18.
10
Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 years.基于肠道微生物群的干预措施用于管理19岁及以下儿童和青少年的肥胖问题。
Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015875. doi: 10.1002/14651858.CD015875.
本文引用的文献
1
Erythropoiesis-stimulating agent responsiveness and hemoglobin variability is associated with fat tissue index in hemodialysis patients with darbepoetin-alfa treatment: a prospective observational cohort study.促红细胞生成素刺激剂反应性和血红蛋白变异性与接受达贝泊汀-α治疗的血液透析患者的脂肪组织指数相关：一项前瞻性观察队列研究。
Kidney Res Clin Pract. 2025 Mar;44(2):299-309. doi: 10.23876/j.krcp.24.070. Epub 2024 Dec 31.
2
Investigation of the Relationship between Lean Muscle Mass and Erythropoietin Resistance in Maintenance Haemodialysis Patients: A Cross-Sectional Study.维持性血液透析患者瘦体重与红细胞生成素抵抗关系的调查：一项横断面研究。
Int J Environ Res Public Health. 2022 May 7;19(9):5704. doi: 10.3390/ijerph19095704.
3
Obesity may be erythropoietin dose-saving in hemodialysis patients.肥胖可能会减少血液透析患者的促红细胞生成素剂量。
Kidney Res Clin Pract. 2018 Jun;37(2):148-156. doi: 10.23876/j.krcp.2018.37.2.148. Epub 2018 Jun 30.
4
Inflammation in end-stage renal disease--what have we learned in 10 years?终末期肾病中的炎症——我们在十年中学到了什么？
Semin Dial. 2010 Sep-Oct;23(5):498-509. doi: 10.1111/j.1525-139X.2010.00784.x.
5
Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness.炎症及其对慢性肾脏病贫血的影响：从血红蛋白变异性到低反应性
NDT Plus. 2009 Jan;2(Suppl_1):i18-i26. doi: 10.1093/ndtplus/sfn176.
6
Hemoglobin variability in anemia of chronic kidney disease.慢性肾脏病贫血中的血红蛋白变异性
J Am Soc Nephrol. 2009 Mar;20(3):479-87. doi: 10.1681/ASN.2007070728. Epub 2009 Feb 11.
7
Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD.体脂量和血清瘦素水平会影响终末期肾病患者对促红细胞生成素的敏感性。
Am J Kidney Dis. 2005 Oct;46(4):628-34. doi: 10.1053/j.ajkd.2005.06.004.
8
High-calorie supplementation increases serum leptin levels and improves response to rHuEPO in long-term hemodialysis patients.高热量补充剂可提高长期血液透析患者的血清瘦素水平并改善其对重组人促红细胞生成素的反应。
Am J Kidney Dis. 2005 Jun;45(6):1073-83. doi: 10.1053/j.ajkd.2005.02.020.
Zotero 插件